Zynnon develops solutions for risk respiratory infection transmission in hospitals and health facilities.
Zynnon has raised $836K in total funding. The most recent round was Seed. The last funding was announced in June 2022.
Zynnon's investors include Innosuisse.
Zynnon is headquartered in Schindellegi, Switzerland.
Zynnon develops solutions for risk respiratory infection transmission in hospitals and health facilities.
Zynnon is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Zynnon — Funding & Investors." VCBacked, June 27, 2022, https://www.vcbacked.co/company/zynnon. Accessed August 14, 2026.
VCBacked. (2022). Zynnon — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/zynnon
{{cite web |title=Zynnon — Funding & Investors |url=https://www.vcbacked.co/company/zynnon |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated